Parents of adolescents and young adults with cystic fibrosis (CF) retain a sense of responsibility for their children as…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
The Cystic Fibrosis (CF) Foundation is giving up to $9 million in additional support to advance clinical testing of…
People with cystic fibrosis (CF) in the U.S. tend to live more than a decade longer now than patients…
BX004, a virus-based cocktail designed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis (CF), can reduce the…
Taking Orkambi (lumacaftor/ivacaftor) for more than two years helped clear trapped air from the lungs of children with…
Treatment with Kaftrio, a triple combo of elexacaftor, tezacaftor, and ivacaftor sold as Trikafta in the U.S., may help…
Both genetics and environmental factors, such as attending daycare, family income, and maternal education, may determine how early some lung…
The Cystic Fibrosis (CF) Foundation will put up to $2 million into an effort by Nosis Bio to use artificial…
Undernutrition, or not getting enough nutrients to meet the body’s needs, may occur in as many as half of hospitalized…
More lumps of fat and hardened deposits, called calcifications, may show up on imaging scans of the pancreas of people…